Phil has been advising entrepreneurs since he joined USVP in 1985. As President and CEO of Macy's California for 11 years, he has focused his investments in the retail sector—from pure retailing plays to the consumer Internet. For example, he guided USVP's investments in PetsMart and Fresh Choice. Phil serves on the boards of Auction Drop, Catalist, Sound ID, and Specialtys .
Phil is a guest lecturer in graduate classrooms at Stanford and Santa Clara University. He has two children, four grandchildren, and a 300-year old elder he looks up to: Emily, a magnificent oak in the center of his Napa Valley property. He has a vineyard where he grows mostly Cabernets. Phil is on the boards of the California College of Art, the San Francisco Botanical Gardens and the diRosa Preserve, a project in the Napa Valley that is seeking to create a public museum to show Rene diRosa's private collection of California artists.
Ives Faroudja is a well-known engineer and inventor in display technology, with expertise in the field of video design, emphasizing high image quality. Ives and his team at Faroudja Laboratories, now a division of Genesis, Inc., have significantly contributed to the improvement of television image quality, and the transitioning to digital processing, HDTV and Flat Panel Display technology. Today, many of his circuitries and algorithms are being incorporated in a large number of TV sets and recorders, most notably in the Asia market.
Faroudja holds over sixty U.S. and foreign patents, and has been the recipient of numerous awards, including three Emmy Awards, Charles F. Jenkins Life Time Achievement Award and the prestigious David Sarnoff Gold Medal.
Faroudja is an M.S. graduate of Paris University, Ecole Superieure d'Electricite. He is a Life Fellow of the Society of Motion Pictures and Television Engineers.
Mike joined NEA in 2002 as a Partner. He specializes in healthcare investments focusing on biotechnology and pharmaceutical sectors. Current board memberships include Amicus Therapeutics (NASDAQ: FOLD), Intarcia, CellGate, Novacea, Hyperion and Macroflux. Mike is also actively involved with 23andMe, Trine Pharmaceuticals, Liquidia and Vitae Pharmaceuticals. As well, Mike is a member of the Life Sciences Advisory Board for Silicon Valley Bank. Prior to joining NEA, Mike was most recently Senior Vice President, Therapeutics and General Manager, of the Renal Division at Genzyme Corporation. Prior to that, Mike was Vice President of Business Development for the Therapeutics Division, responsible for the identification and in-licensing of new therapeutic product opportunities. He gained extensive international experience while building a commercial operation in Latin America for the Therapeutics and Surgical Products groups for the company. Mike was also Product Manager for Ceredase and was instrumental in the worldwide launch of Cerezyme, Genzyme’s $1 Billion therapies for Gaucher Disease. Mike also spent two years with Genzyme’s Diagnostic products and services division. Previous to Genzyme, Mike held sales and marketing positions at Repligen and Bristol-Myers. Mike received his BA from DePauw University.
In addition to serving as a venture partner at Benchmark, Rich is Chairman and CEO of Zillow Inc., an online real estate service dedicated to providing home buyers and sellers with valuable tools and information.
Prior to Zillow, Rich founded Expedia within Microsoft. In 1999, he led the spin-off of Expedia from Microsoft and served as the company’s president and CEO until March, 2003, by which time Expedia had grown to become the world’s largest online travel retailer.
Prior to founding Expedia, Rich worked in various product management roles on Windows and MS-DOS at Microsoft.
Board Seats: Rich serves as a director of Avvo and Netflix (Nasdaq: NFLX).
Education: Rich holds a BS degree in industrial engineering from Stanford University.